• "I must consider the best interests of Bristol-Myers Squibb Company and its shareholders, " Dolan wrote.

    FORBES: Magazine Article

  • Among the largest underlying components of PJP, in trading today Prestige Brands Holdings ( PBH) is down about 0.7%, and Bristol Myers Squibb Company ( BMY) is up by about 0.2%.

    FORBES: Pharmaceuticals See Big Inflows

  • Among the largest underlying components of HDV, in trading today ConocoPhillips ( NYSE: COP) is up about 0.3%, Altria Group Incorporated ( NYSE: MO) is up about 0.2%, and Bristol Myers Squibb Company ( NYSE: BMY) is lower by about 0.1%.

    FORBES: Juicy Dividends Lure Investors Back Into Equities

  • Among the largest underlying components of HDV, in trading today Intel Corporation ( NASD: INTC) is up about 0.4%, Altria Group Incorporated ( NYSE: MO) is up about 1.1%, and Bristol Myers Squibb Company ( NYSE: BMY) is higher by about 1.4%.

    FORBES: Investors Boost High Yield Dividend Holdings

  • Among the largest underlying components of PJP, in trading today Prestige Brands Holdings Incorporated ( NYSE: PBH) is up about 0.6%, Bristol Myers Squibb Company ( NYSE: BMY) is off about 0.9%, and The Medicines Company ( NASD: MDCO) is higher by about 0.3%.

    FORBES: Noteworthy ETF Outflows: PJP, PBH, BMY, MDCO

  • Among the largest underlying components of OEF, in trading today Occidental Petroleum Corporation ( NYSE: OXY) is up about 0.9%, Bank of America Corporation ( NYSE: BAC) is down about 0.7%, and Bristol Myers Squibb Company ( NYSE: BMY) is higher by about 1.4%.

    FORBES: OEF, OXY, BAC, BMY: Large Outflows Detected at ETF

  • Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has determined that additional time is required to complete the review of the biologics license application (BLA) for ipilimumab in pre-treated advanced melanoma, and has moved its decision date from December 25, 2010 to March 26, 2011.

    FORBES: Immune-Boosting Cancer Drug Hits FDA Delay

  • Bristol-Myers Squibb, a big pharmaceuticals company, also certified its results with caveats.

    ECONOMIST: Swearing by the numbers

  • Soon after Qwest Communications, the biggest local-telephone company in 14 states, joined the list of firms under investigation, it was revealed that the Securities and Exchange Commission (SEC) is looking into the sales practices of Bristol-Myers Squibb, a big drug company.

    ECONOMIST: Congress gets tough | The

  • The last drug company to try and buy a potential blockbuster from a biotechnology company was Bristol-Myers Squibb (nyse: BMY - news - people ).

    FORBES: How Will Pharmacia Spend Its New Money?

  • But the best fit may be with a U.S. company, such as Bristol-Myers Squibb, Abbot Labs or even Baxter International.

    FORBES: Beyond the bad at Bayer

  • But because Novartis' field force is still smaller than Pfizer's or GlaxoSmithKline's, the company has signed on Bristol-Myers Squibb to comarket Zelmac.

    FORBES: Reviving Novartis

  • It helps Bristol-Myers Squibb play in the emerging hepatitis C market by giving the company full control of the drug the two firms were developing together.

    FORBES: Bristol's Smart Buy

  • Vasella has been playing the waiting game quite a bit--analysts love to speculate that Novartis will buy another drug company, like Roche or maybe Bristol-Myers Squibb (nyse: BMY - news - people ).

    FORBES: Novartis CEO Plays Waiting Game

  • Among the chemotherapy medicines that bind to tubulin are Taxol, the drug that built Bristol-Myers Squibb (nyse: BMY - news - people ) as an oncology company, and Taxotere, the current lynchpin in Aventis ' (nyse: AVE - news - people ) anti-cancer stable.

    FORBES: Investors Applaud Tularik's Baby Step

  • Bristol-Myers Squibb ( BMY - news - people ) moved slightly higher after a federal panel said the company's diabetes drug appears free from the kinds of heart problems seen with similar drugs.

    FORBES: This is a transcript of the After Hours video report.

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定